Sprinklr (CXM) Tops Q4 EPS by 4c; offers guidance
Get Alerts CXM Hot Sheet
Price: $7.47 --0%
Financial Fact:
Research and development: 108.67K
Today's EPS Names:
EGRX, VAXX, AFIB, More
Financial Fact:
Research and development: 108.67K
Today's EPS Names:
EGRX, VAXX, AFIB, More
Join SI Premium – FREE
Sprinklr (NYSE: CXM) reported Q4 EPS of $0.13, $0.04 better than the analyst estimate of $0.09. Revenue for the quarter came in at $194.2 million versus the consensus estimate of $188.75 million.
GUIDANCE:
Sprinklr sees Q1 2025 EPS of $0.07, versus the consensus of $0.09. Sprinklr sees Q1 2025 revenue of $194-195 million, versus the consensus of $193.3 million.
Sprinklr sees FY2025 EPS of $0.38-$0.39, versus the consensus of $0.39. Sprinklr sees FY2025 revenue of $804.5-805.5 million, versus the consensus of $802.1 million.
For earnings history and earnings-related data on Sprinklr (CXM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Phibro Animal Health (PAHC) Tops Q4 EPS by 13c; Offers Guidance
- Kohl's (KSS) Tops Q2 EPS by 71c; raises guidance
- Abercrombie & Fitch (ANF) Tops Q2 EPS by $2.19, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share